Works matching IS 1758-8340 AND DT 2022

Results: 187
    1

    Cost-effectiveness analysis of Oncotype DX from a Brazilian private medicine perspective: a GBECAM multicenter retrospective study.

    Published in:
    Therapeutic Advances in Medical Oncology, 2022, v. 14, p. 1, doi. 10.1177/17588359221141760
    By:
    • Oliveira, Leandro Jonata Carvalho;
    • Megid, Thais Baccili Cury;
    • Rosa, Daniela Dornelles;
    • Magliano, Carlos Alberto da Silva;
    • Assad, Daniele Xavier;
    • Argolo, Daniel Fontes;
    • Sanches, Solange Moraes;
    • Testa, Laura;
    • Bines, José;
    • Kaliks, Rafael;
    • Caleffi, Maira;
    • de Melo Gagliato, Debora;
    • Sahade, Marina;
    • Barroso-Sousa, Romualdo;
    • Corrêa, Tatiana Strava;
    • Shimada, Andrea Kazumi;
    • Batista, Daniel Negrini;
    • Musse Gomes, Daniel;
    • Cesca, Marcelle Goldner;
    • Gaudêncio, Débora
    Publication type:
    Article
    2
    3
    4

    Predictive value of vascular endothelial growth factor polymorphisms for maintenance bevacizumab efficacy in metastatic colorectal cancer: an ancillary study of the PRODIGE 9 phase III trial.

    Published in:
    Therapeutic Advances in Medical Oncology, 2022, v. 14, p. 1, doi. 10.1177/17588359221141307
    By:
    • de Rauglaudre, Bernadette;
    • Sibertin-Blanc, Camille;
    • Fabre, Aurélie;
    • Le Malicot, Karine;
    • Bennouna, Jaafar;
    • Ghiringhelli, François;
    • Taïeb, Julien;
    • Boige, Valérie;
    • Bouché, Olivier;
    • Chatellier, Thierry;
    • Faroux, Roger;
    • François, Eric;
    • Jacquot, Stéphane;
    • Genet, Dominique;
    • Mulot, Claire;
    • Olschwang, Sylviane;
    • Seitz, Jean-François;
    • Aparicio, Thomas;
    • Dahan, Laetitia
    Publication type:
    Article
    5

    Cancer immune profiling unveils biomarkers, immunological pathways, and cell type score associated with glioblastoma patients' survival.

    Published in:
    Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221127678
    By:
    • Moreno, Daniel Antunes;
    • da Silva, Luciane Sussuchi;
    • Gomes, Isabella;
    • Leal, Letícia Ferro;
    • Berardinelli, Gustavo Noriz;
    • Gonçalves, Gisele Melo;
    • Pereira, Caio Augusto;
    • Santana, Iara Viana Vidigal;
    • Matsushita, Marcus de Medeiros;
    • Bhat, Krishna;
    • Lawler, Sean;
    • Reis, Rui Manuel
    Publication type:
    Article
    6
    7

    A phase II study of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small-cell lung cancer in Japan (SAMURAI study): primary analysis.

    Published in:
    Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221142786
    By:
    • Tanaka, Hisashi;
    • Tanzawa, Shigeru;
    • Misumi, Toshihiro;
    • Makiguchi, Tomonori;
    • Inaba, Megumi;
    • Honda, Takeshi;
    • Nakamura, Junya;
    • Inoue, Koji;
    • Kishikawa, Takayuki;
    • Nakashima, Masanao;
    • Fujiwara, Keiichi;
    • Kohyama, Tadashi;
    • Ishida, Hiroo;
    • Kuyama, Shoichi;
    • Miyazawa, Naoki;
    • Nakamura, Tomomi;
    • Miyawaki, Hiroshi;
    • Oda, Naohiro;
    • Ishikawa, Nobuhisa;
    • Morinaga, Ryotaro
    Publication type:
    Article
    8
    9
    10
    11
    12
    13
    14

    Genetic landscape of colorectal cancer patients manifesting tumor shrinkage during SARS-Cov-2 infection.

    Published in:
    Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221138388
    By:
    • Ottaiano, Alessandro;
    • Santorsola, Mariachiara;
    • Circelli, Luisa;
    • Cascella, Marco;
    • Petrillo, Nadia;
    • Perri, Francesco;
    • Casillo, Marika;
    • Granata, Vincenza;
    • Ianniello, Monica;
    • Izzo, Francesco;
    • Picone, Carmine;
    • Correra, Marco;
    • Petrillo, Antonella;
    • Sirica, Roberto;
    • Misso, Gabriella;
    • Delrio, Paolo;
    • Nasti, Guglielmo;
    • Savarese, Giovanni;
    • Caraglia, Michele
    Publication type:
    Article
    15
    16
    17

    Clearance of ctDNA in triple-negative and HER2-positive breast cancer patients during neoadjuvant treatment is correlated with pathologic complete response.

    Published in:
    Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221139601
    By:
    • Ciriaco, Nikaoly;
    • Zamora, Esther;
    • Escrivá-de-Romaní, Santiago;
    • Miranda Gómez, Ignacio;
    • Jiménez Flores, José;
    • Saura, Cristina;
    • Sloane, Hillary;
    • Starus, Anna;
    • Fredebohm, Johannes;
    • Georgieva, Lucy;
    • Speight, Graham;
    • Jones, Frederick;
    • Ramón y Cajal, Santiago;
    • Espinosa-Bravo, Martín;
    • Peg, Vicente
    Publication type:
    Article
    18
    19
    20

    An open label, safety study of Asian patients with advanced non-small-cell lung cancer receiving second-line nivolumab monotherapy (CheckMate 870).

    Published in:
    Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221138380
    By:
    • Lu, Shun;
    • Cheng, Ying;
    • Zhou, Jianying;
    • Wang, Mengzhao;
    • Zhao, Jun;
    • Wang, Baocheng;
    • Chen, Gongyan;
    • Feng, Jifeng;
    • Ma, Zhiyong;
    • Wu, Lin;
    • Wang, Changli;
    • Ma, Kewei;
    • Zhang, Shucai;
    • Liang, Jun;
    • Song, Yong;
    • Wang, Jie;
    • Wu, Yi-Long;
    • Li, Ang;
    • Huang, Yizhi;
    • Chang, Jianhua
    Publication type:
    Article
    21

    Improved overall survival of metastatic renal cell carcinoma patients in the era of modern tyrosine kinase inhibitors and immune checkpoint inhibitors: results from a real-life, population-based Austrian study comprising three decades of follow-up.

    Published in:
    Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221134065
    By:
    • Fluhrer, Hannah;
    • Hutterer, Georg C.;
    • Golbeck, Sylvia;
    • Stidl, Michael;
    • Niedrist, Tobias;
    • Pichler, Renate;
    • Mischinger, Johannes;
    • Seles, Maximilian;
    • Mannweiler, Sebastian;
    • Spiegelberg, Jasmin;
    • Bauernhofer, Thomas;
    • Jost, Philipp J.;
    • Ahyai, Sascha;
    • Zigeuner, Richard;
    • Pichler, Martin;
    • Barth, Dominik A.
    Publication type:
    Article
    22
    23
    24
    25
    26
    27
    28

    Data collection framework for electronic medical record-based real-world data to evaluate the effectiveness and safety of cancer drugs: a nationwide real-world study of the Korean Cancer Study Group.

    Published in:
    Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221132628
    By:
    • Han, Hye Sook;
    • Lee, Kyoung Eun;
    • Suh, Young Ju;
    • Jee, Hee-Jung;
    • Kim, Bum Jun;
    • Kim, Hyeong Su;
    • Lee, Keun-Wook;
    • Ryu, Min-Hee;
    • Baek, Sun Kyung;
    • Park, In Hae;
    • Ahn, Hee Kyung;
    • Jeong, Jae Ho;
    • Kim, Min Hwan;
    • Lee, Dae Hyung;
    • Kim, Siheon;
    • Moon, Hyemi;
    • Son, Serim;
    • Byun, Ji-Hye;
    • Kim, Dong Sook;
    • An, Hyonggin
    Publication type:
    Article
    29

    Circulating tumour DNA biomarkers in savolitinib-treated patients with non-small cell lung cancer harbouring MET exon 14 skipping alterations: a post hoc analysis of a pivotal phase 2 study.

    Published in:
    Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221133546
    By:
    • Yu, Yongfeng;
    • Ren, Yongxin;
    • Fang, Jian;
    • Cao, Lejie;
    • Liang, Zongan;
    • Guo, Qisen;
    • Han, Sen;
    • Ji, Zimei;
    • Wang, Ye;
    • Sun, Yulan;
    • Chen, Yuan;
    • Li, Xingya;
    • Xu, Hua;
    • Zhou, Jianying;
    • Jiang, Liyan;
    • Cheng, Ying;
    • Han, Zhigang;
    • Shi, Jianhua;
    • Chen, Gongyan;
    • Ma, Rui
    Publication type:
    Article
    30
    31
    32
    33

    Comorbidity between lung cancer and COVID-19 pneumonia: role of immunoregulatory gene transcripts in high ACE2 -expressing normal lung.

    Published in:
    Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221133893
    By:
    • Lazar, Vladimir;
    • Raynaud, Jacques;
    • Magidi, Shai;
    • Bresson, Catherine;
    • Martini, Jean-François;
    • Galbraith, Susan;
    • Wunder, Fanny;
    • Onn, Amir;
    • Batist, Gerald;
    • Girard, Nicolas;
    • Lassen, Ulrik;
    • Pramesh, C. S.;
    • Al-Omari, Amal;
    • Ikeda, Sadakatsu;
    • Berchem, Guy;
    • Blay, Jean-Yves;
    • Solomon, Benjamin;
    • Felip, Enriqueta;
    • Tabernero, Josep;
    • Rubin, Eitan
    Publication type:
    Article
    34

    Progression-free survival as surrogate endpoint of overall survival in esophageal squamous cell carcinoma: a real-world data and literature-based analysis.

    Published in:
    Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221131526
    By:
    • Han, Weiming;
    • Wang, Lan;
    • Li, Chen;
    • Chen, Junqiang;
    • Zhang, Wencheng;
    • Wang, Xin;
    • Pang, Qingsong;
    • Zhao, Yidian;
    • Sun, Xinchen;
    • Zhang, Kaixian;
    • Li, Gaofeng;
    • Li, Ling;
    • Qiao, Xueying;
    • Liu, Miaoling;
    • Wang, Yadi;
    • Deng, Lei;
    • Wang, Wenqing;
    • Bi, Nan;
    • Zhang, Tao;
    • Deng, Wei
    Publication type:
    Article
    35
    36
    37
    38

    A prospective, open-label, multicenter phase IV clinical trial on the safety and efficacy of lobaplatin-based chemotherapy in advanced breast cancer.

    Published in:
    Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221122715
    By:
    • Yan, Min;
    • Yuan, Peng;
    • Ouyang, Quchang;
    • Cheng, Ying;
    • Han, Guohui;
    • Wang, Dewei;
    • Ran, Li;
    • Sun, Tao;
    • Zhao, Da;
    • Bai, Yuju;
    • Yang, Shun'e;
    • Wang, Xiaojia;
    • Wu, Rong;
    • Zeng, Xiaohua;
    • Yao, Herui;
    • Ji, Xuening;
    • Jiang, Jun;
    • Hu, Xiaohua;
    • Lin, Haifeng;
    • Zheng, Liping
    Publication type:
    Article
    39
    40
    41
    42

    Serendipitous synergism – an exceptional response to treatment with pembrolizumab in the course of a natural immunovirotherapy: a case report and review of the literature.

    Published in:
    Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221122729
    By:
    • Khoury, Lara M.;
    • Burcher, Kimberly M.;
    • Ng, Ronald T.;
    • Song, Alexander H.;
    • Chang, Mark J.;
    • Gavrila, Elena;
    • Bloomer, Chance H.;
    • Robinson, Mac B.;
    • Kouri, Brian E.;
    • Waltonen, Joshua D.;
    • Bunch, Paul M.;
    • Lauer, Ulrich M.;
    • Porosnicu, Mercedes
    Publication type:
    Article
    43
    44
    45
    46
    47
    48

    The diagnostic accuracy of PIK3CA mutations by circulating tumor DNA in breast cancer: an individual patient data meta-analysis.

    Published in:
    Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221110162
    By:
    • Galvano, Antonio;
    • Castellana, Luisa;
    • Gristina, Valerio;
    • La Mantia, Maria;
    • Insalaco, Lavinia;
    • Barraco, Nadia;
    • Perez, Alessandro;
    • Cutaia, Sofia;
    • Calò, Valentina;
    • Bazan Russo, Tancredi Didier;
    • Francini, Edoardo;
    • Incorvaia, Lorena;
    • Mirisola, Mario Giuseppe;
    • Vieni, Salvatore;
    • Rolfo, Christian;
    • Bazan, Viviana;
    • Russo, Antonio
    Publication type:
    Article
    49

    An update on treatment of penile cancer.

    Published in:
    Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221127254
    By:
    • Chadha, Juskaran;
    • Chahoud, Jad;
    • Spiess, Philippe E.
    Publication type:
    Article
    50